Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iron Catalyzed Selenylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112174957B details an efficient Fe(OTf)3-catalyzed route to 5-selenoindoloisoquinolinones, offering a scalable solution for anticancer pharmaceutical intermediates.
Patent CN110305054B details a green FeBr3-catalyzed route for N-(1-phenyl-2-(phenylseleno)ethyl)aniline derivatives, offering cost reduction and scalable manufacturing.